1. Drug Interactions as a Potential Instrumental Variable: The Example of Effectiveness of Antibiotic Therapy in Exacerbated COPD Patients

   Wang, Y., Jansen, A., Bos, J. & Hak, E., Aug-2016, In : Pharmcoepidemiology and Drug Safety. 25, S3, p. 554-555

   Research output: Contribution to journal › Meeting Abstract › Academic

2. Real-world data on the effect of doxycycline plus prednisone/prednisolone on COPD exacerbations compared with prednisone/prednisolone alone: A retrospective cohort study among COPD outpatients

   Wang, Y., Bos, J., Schuiling-Veninga, C., Wilffert, B. & Hak, E., Aug-2018, In : Pharmcoepidemiology and Drug Safety. 27, p. 496-496

   Research output: Contribution to journal › Meeting Abstract › Academic

3. Prevalence and Accuracy of Information on CYP2D6, CYP2C19, and CYP2C9 Related Substrate and Inhibitor Co-Prescriptions in the General Population: A Cross-Sectional Descriptive Study as Part of the PharmLines Initiative

   Bahar, M. A., Bos, J. H. J., Borgsteede, S. D., Dotinga, A., Alingh, R. A., Wilffert, B. & Hak, E., 8-May-2020, In : Frontiers in Pharmacology. 11, 12 p., 624.

   Research output: Contribution to journal › Article › Academic › peer-review

4. Persistence of Antipsychotic Use After Clozapine Discontinuation: A Real-World Study Across Antipsychotics

   Stam, N., Taipale, H., Tanskanen, A., Isphording, L., Okhuijsen-Pfeifer, C., Schuiling-Veninga, C. C. M., Bos, J. H. J., Bijker, B. J., Tiihonen, J. & Luykx, J. J., 22-May-2020, In : Clinical and translational science. 8 p.

   Research output: Contribution to journal › Article › Academic › peer-review

5. Influence of age on real-life effects of doxycycline for acute exacerbations among COPD outpatients: a population-based cohort study

   Wang, Y., Bos, J., Boezen, H. M., Alffenaar, J-W., Boven, van, J., Schuiling-Veninga, C., Wilffert, B. & Hak, E., Feb-2020, In : BMJ Open Respir Res. 7, 1, e000535.

   Research output: Contribution to journal › Article › Academic › peer-review

View all (109) »